newsfilter
← Latest News
GlobeNewswire·

Kineta to Present at the Life Sciences Investor Forum December 14th

KA

SEATTLE, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (NASDAQ:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance,